IMIQUIMOD vs ZYCLARA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Attribute	IMIQUIMOD	ZYCLARA
Rating	70/100	New
Pharmacy pays	~$350.38 /30	~$350.38 /30
Type	RX	RX
Active ingredient	IMIQUIMOD	IMIQUIMOD
Manufacturer	Taro	Bausch
Dosage forms	Topical	Topical
Drug class	—	—
Boxed warning	None	None
Treats	Basal Cell Carcinoma, Condylomata Acuminata, Actinic Keratosis	Basal Cell Carcinoma, Condylomata Acuminata, Actinic Keratosis

imiquimod zyclara

Rating

70/100

New

Pharmacy pays

~$350.38 /30

Type

Active ingredient

IMIQUIMOD

Manufacturer

Taro

Bausch

Dosage forms

Topical

Drug class

—

Boxed warning

None

Treats

Basal Cell Carcinoma, Condylomata Acuminata, Actinic Keratosis

Frequently asked questions

Which is cheaper, Imiquimod or Zyclara?

Pharmacies pay about the same to acquire either one — roughly $350.38 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Imiquimod and Zyclara?

Both Imiquimod and Zyclara share the active ingredient Imiquimod.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.